Venture Summit Virtual Connect | Global 21, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of venture backed, emerging and early stage companies, university researchers, incubators and premier service providers. Whether you are an investor seeking access to new deals, or founder...
Networking with Investors – From Getting a Business Card to Getting the Check Wednesday, July 7, 2021, 3-4pm Mystified about how startups raise funds? Listen to an experienced venture lawyer walk participants through the process of finding and meeting angel investors and venture capitalists.
Billions of years of evolution have proteins that perform incredibly specialized functions. But evolution must take a continuous path. What if, given all we now know about how structure relates to function, we could shortcut evolution and custom-design proteins for our own aims? We can. In this talk, David Baker of the University of Washington's...
Join us for breakfast, lunch, or cocktails in your local time zone for our monthly webinar series on bioentrepreneurship. In this "Things I Wish I Knew" series, we will learn from prominent scientists, entrepreneurs, and investors about their successes, struggles, and the things they wished they knew before starting their journey. "CELL THERAPY" This Seminar...
Hosted by Boston Taiwanese Biotechnology Association (BTBA) for biotech professionals in academia or industry to learn and connect virtually Boston Taiwanese Biotechnology Association (BTBA) will hold the 2021 BTBA Virtual Annual Symposium from 12:50 pm to 6:30 pm EDT on July 10 & 11 (Saturday and Sunday) 2021. This online symposium will bring experts from...
Held annually in Napa and Europe, the Biotech CEO Summits provide high-value, relationship-building opportunities through informal discussions where personal knowledge, insights, and ideas are exchanged with peers. These candid discussions take place in a secure, confidential setting. Who Participates Biotech CEO Summits are limited to CEOs focused on leading their organizations through the ever-evolving biotech...
Come here for the cutting edge Technologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit will take you inside these innovations, examining how they're being developed, adopted, and paid for. We'll also take a look at the breakthroughs that haven't yet hit the...
Community Relations Special Event Partnership Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. This evolving form of therapy is designed to prime the body’s own immune system to fight the disease head-on. Doctors report promising results, including...
Solid state chemistry, polymorphic forms of the drug and the ability to scale up manufacturing are very important details that define the identity as well as feasibility of a drug. Very minor changes in any or each of these aspects of the drug can pivot chances of scale up, or a process to launch or...
We are very excited to announce our outdoor Summer Biotech Community Event at the Tech Square Courtyard. All the biotech tenants at 100-500 Technology Square and other companies in the Cambridge vicinity will be invited to attend this event. The event is being promoted as a special Biotech Community Event sponsored by the best scientific...
Speaker: Jie Jack Li, PhD has practiced medicinal chemistry since 1997 at Pfizer, BMS, and Revolution Medicines, respectively, with a four-year sojourn at the University of San Francisco as an Associate Professor, teaching organic and medicinal chemistry. He is currently a vice president of Discovery Chemistry at ChemPartner, splitting his time between San Francisco and...
COVID-19 has ignited biotech and digital health investment activity – from telemedicine to drug trial technology to precision genomics. In 2020, biotech IPO’s continued to pique investor interest and venture capital fundraising in healthcare reached record levels- and 2021 shows no sign of abating. According to Crunchbase, there has been $4.1B+ in health-related investment deals this year...
